Picture of Eris Lifesciences logo

ERIS — Eris Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

India's Eris Lifesciences gains on strong quarterly results

BUZZ-India's Eris Lifesciences gains on strong quarterly results

** Shares of Eris Lifesciences ERIS.NS rise to 2.4% to 1,122.70 rupees

** Pharmaceuticals co says September-quarter consolidated net profit increased y/y 53%, consolidated revenue increased about 13%

** Says won approval to conduct Phase 1 and Phase 3 trials for India's first recombinant semaglutide, a diabetes and weight-loss drug

** Stock rated "buy" on avg by 11 analysts, with median PT of 1,670 rupees - data compiled by LSEG

** Stock down about 26% YTD


(Reporting by Anushka Rajvedi in Bengaluru)

((mailto: anushka.rajvedi@thomsonreuters.com))

Recent news on Eris Lifesciences

See all news